|
- Anemia and bleeding in patients receiving anticoagulant therapy for . . .
During anticoagulation for VTE, both cancer- and non-cancer anemic patients had a higher risk for major bleeding than those without anemia In anemic patients (with or without cancer), the rate of major bleeding during the course of anticoagulant therapy exceeded the rate of VTE recurrences
- Impact of Anemia Management on Bleeding Outcomes in Anticoagulated . . .
This project evaluated the association between anticoagulation use and anemia, focusing on baseline hemoglobin levels, anemia management, monitoring practices, measures taken if anemia was present prior to initiation, and bleeding events
- Oral Anticoagulant Use for Patients with Atrial Fibrillation with . . .
Hemoglobin levels and platelet counts have been associated with adverse clinical outcomes in patients with cardiovascular conditions We aimed to assess the impact of oral anticoagulant use for patients with atrial fibrillation and concomitant anemia or thrombocytopenia
- Anemia Anticoagulation - CureHHT
These six guidelines cover testing and treatment of iron deficiency and anemia, as well as the use of anticoagulation therapy Full background can be found after the recommendations
- Anticoagulation and anaemia: old opponents from the era of VKA?
Anticoagulation and anaemia: old opponents from the era of VKA? Published on behalf of the European Society of Cardiology All rights reserved © The Author (s) 2019 For permissions, please email: journals permissions@oup com
- Impact of Anemia on Clinical Outcomes in Atrial Fibrillation Patients . . .
Anemia is frequently observed as a comorbidity in atrial fibrillation (AF), especially in elderly patients and in those on anticoagulation This has been associated with poor clinical outcomes
- Sustained resolution of anticoagulation related iron deficiency anemia . . .
We present a series of iron deficiency anemia cases where switching to apixaban was the cornerstone of management and demonstrated sustained resolution of anemia
- Anemia and bleeding in patients receiving anticoagulant therapy for . . .
We read with a great attention the recently published study of Kuperman et al on Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism (VTE) [1]
|
|
|